300871 深市 回盛生物

                              武汉回盛生物科技股份有限公司

                2024 年半年度非经营性资金占用及其他关联资金往来情况汇总表

编制单位：武汉回盛生物科技股份有限公司                                                              金额单位：人民币元

                                  占用方                        2024 年半年度2024 年半年

                                  与上市 上市公司核算 2024年期初 占用累计发生 度占用资金 2024 年半年 2024 年 6 月末 占用形

 非经营性资金占用 资金占用方名称 公司的  的会计科目 占用资金余 金额（不含利 的利息（如 度偿还累计 占用资金余额 成原因  占用性质
                                  关联关                  额        息）      有）    发生金额

                                    系

控股股东、实际控制      -          -        -          -          -          -          -          -        -        -

人及其附属企业

      小计              -          -        -          -          -          -          -          -        -        -

前控股股东、实际控      -          -        -          -          -          -          -          -        -        -

制人及其附属企业

      小计              -          -        -          -          -          -          -          -        -        -

其他关联方及附属企      -          -        -          -          -          -          -          -        -        -

业

      小计              -          -        -          -          -          -          -          -        -        -

      总计              -          -        -          -          -          -          -          -        -        -


                                往来方与 上市公司核            2024 年半年度 2024 年半 2024 年半年度                        往来性质
 其它关联资金往来 资金往来方名称 上市公司 算的会计科2024 年期初往往来累计发生金 年度往来 偿还累计发生 2024 年 6 月末 往来形成 （经营性往
                                的关联关    目    来资金余额 额（不含利息） 资金的利    金额    往来资金余额  原因  来、非经营性
                                  系                                        息（如有）                                    往来）

控股股东、实际控制
人及其附属企业

                  湖北回盛生物科 子公司 其他应收款 155,762,796.94 144,180,241.93          140,000,000.00 159,943,038.87 垫付及资 非经营性往
                  技有限公司                                                                                      金往来      来

                  武汉新华星动物                                                                                  垫付及资 非经营性往
                  保健连锁服务有 子公司 其他应收款  5,019,080.76    19,456.00            5,000,000.00    38,536.76 金往来      来

上市公司的子公司及限公司

其附属企业        长沙施比龙动物                                                                                  垫付及资 非经营性往
                  药业有限公司  子公司 其他应收款        16.79    17,596.28              17,596.28        16.79 金往来      来

                  奇迹医药有限公 子公司 其他应收款              24,498,183.33                        24,498,183.33 垫付及资 非经营性往
                  司                                                                                              金往来      来

      小计                                        160,781,894.49 168,715,477.54      0.00 145,017,596.28 184,479,775.75

其他关联方及其附属
企业

      总计                                        160,781,894.49 168,715,477.54      0.00 145,017,596.28 184,479,775.75

公司负责人：张卫元                                    主管会计工作的负责人：杨凯杰                          会计机构负责人：罗琼碧